Genovis AB (publ.) (STO:GENO)
Sweden · Delayed Price · Currency is SEK 20.35
-0.10 (-0.49%)
Dec 5, 2025, 5:29 PM CET
Genovis AB (publ.) Revenue
Genovis AB (publ.) had revenue of 27.74M SEK in the quarter ending September 30, 2025, a decrease of -16.61%. This brings the company's revenue in the last twelve months to 117.66M, down -10.31% year-over-year. In the year 2024, Genovis AB (publ.) had annual revenue of 131.32M, down -17.44%.
Revenue (ttm)
117.66M
Revenue Growth
-10.31%
P/S Ratio
11.48
Revenue / Employee
3.27M
Employees
32
Market Cap
1.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 131.32M | -27.75M | -17.44% |
| Dec 31, 2023 | 159.07M | 55.51M | 53.60% |
| Dec 31, 2022 | 103.56M | 9.89M | 10.55% |
| Dec 31, 2021 | 93.68M | 32.65M | 53.49% |
| Dec 31, 2020 | 61.03M | 480.58K | 0.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.57B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |
Genovis AB (publ.) News
- 1 year ago - Genovis AB (OSTO:GENO) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus